Cardiovascular toxicities associated with abiraterone compared to enzalutamide–A pharmacovigilance study

BACKGROUND: Androgen deprivation therapy (ADT) is standard-of-care for advanced prostate cancer. Studies have generally found increased cardiovascular risks associated with ADT, but the comparative risk of newer agents is under-characterized. We defined the cardiac risks of abiraterone and enzalutam...

Descripción completa

Detalles Bibliográficos
Autores principales: Cone, Eugene B., Reese, Stephen, Marchese, Maya, Nabi, Junaid, McKay, Rana R., Kilbridge, Kerry L., Trinh, Quoc-Dien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257986/
https://www.ncbi.nlm.nih.gov/pubmed/34308305
http://dx.doi.org/10.1016/j.eclinm.2021.100887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257986/
https://www.ncbi.nlm.nih.gov/pubmed/34308305
http://dx.doi.org/10.1016/j.eclinm.2021.100887

Ejemplares similares